SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 490 filers reported holding SEATTLE GENETICS INC in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $242,000 | +4.8% | 1,425 | -28.8% | 0.04% | -11.4% |
| Q1 2020 | $231,000 | -60.6% | 2,000 | -61.1% | 0.04% | -46.3% |
| Q4 2019 | $587,000 | +33.7% | 5,135 | 0.0% | 0.08% | +20.6% |
| Q3 2019 | $439,000 | +23.7% | 5,135 | 0.0% | 0.07% | +51.1% |
| Q2 2019 | $355,000 | -5.6% | 5,135 | 0.0% | 0.04% | -15.1% |
| Q1 2019 | $376,000 | +29.2% | 5,135 | 0.0% | 0.05% | +8.2% |
| Q4 2018 | $291,000 | -26.5% | 5,135 | 0.0% | 0.05% | -15.5% |
| Q3 2018 | $396,000 | +16.1% | 5,135 | 0.0% | 0.06% | -6.5% |
| Q2 2018 | $341,000 | +36.4% | 5,135 | +7.5% | 0.06% | +37.8% |
| Q1 2018 | $250,000 | -2.0% | 4,775 | 0.0% | 0.04% | 0.0% |
| Q4 2017 | $255,000 | -1.9% | 4,775 | 0.0% | 0.04% | -4.3% |
| Q3 2017 | $260,000 | – | 4,775 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |